Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Muhammad Kashif Amin, Muhammad Asad Shabbir, Nabeeha Noor, Abdullah Masood, Maham Rasool, Muhammad Ali Lak, Qasim Chohdry, Hammad Shafi, Ezza Bashir, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7692.

https://doi.org/10.1182/blood-2025-7692

Published: 2025

Journal Articles

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Amir Kasaeian, Moazzam Shahzad, Zeeshan Sattar, Muhammad Kashif Amin, Hediyeh Alemi, Forat Lutfi, Mehdi Hamadani, Rajat Bansal, Alma Habib, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 934.

https://doi.org/10.1182/blood-2025-934

Published: 2025

Journal Articles

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Areeba Ismail, Amna Bint I Munir, Fatima Imran, Muhammad Shahzou Shah, Zunaira Amjad, Muhammad Zeeshan, Hammad Shafi, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7733.

https://doi.org/10.1182/blood-2025-7733

Published: 2025

Journal Articles

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Aqeeb Ur Rehman, Moazzam Shahzad, Shah Rukh, Zeeshan Sattar, Muhammad Kashif Amin, Jeries Kort, Al-Ola Abdallah, Leyla Shune, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 5985.

https://doi.org/10.1182/blood-2025-5985

Published: 2025

Journal Articles

Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)

Blood (2025) 146 (Supplement 1): 667.

https://doi.org/10.1182/blood-2025-667

Published: 2025

Journal Articles

Novel composite end-points toxicity/progression-free survival (tfPFS) and toxicity-free complete remission (tfCR100) after CAR-T cell therapy for diffuse large B cell lymphoma: Cell therapy consortium analysis.

Veronika Bachanova, Qing Cao, Marie Hu, Supriya Gupta, Miguel-Angel Perales, Olalekan Oluwole, Richard Maziarz, Joseph McGuirk, Andy Chen, Stephen J. Schuster, Gunjan Shah, Anthony Hunter, Jamie Brower, David Porter, Peter Riedell

Blood (2025) 146 (Supplement 1): 400.

https://doi.org/10.1182/blood-2025-400

Published: 2025

Journal Articles

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Muhammad Kashif Amin, Tehseen Raza, Hira Habib, Nabeeha Noor, Muhammad Usman, Fatima Imran, Rameen Fatima, Muhammad Zohaib Qasim, Hammad Shafi, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 6320.

https://doi.org/10.1182/blood-2025-6320

Published: 2025

Journal Articles

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Shah Rukh, Aroog Khaliq, Aqeeb Ur Rehman, Amna Bint I Munir, Muhammad Kashif Amin, Amir Kasaeian, Anthony Sung, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4200.

https://doi.org/10.1182/blood-2025-4200

Published: 2025

Journal Articles

Absolute lymphocyte count (ALC) at apheresis and infusion as a predictor of safety and efficacy for multiple myeloma and B cell malignancies post CAR-T therapy

Raeef Rahman, Isuru Ratnayake, Jianzheng Wu, Lauren Scott, William Wesson, Razan Mansour, Marc Hoffmann, Aung Tun, Joseph Bennett, Al-Ola Abdallah, Muhammad Mushtaq, Dinesh Mudaranthakam, Joseph McGuirk, Nausheen Ahmed, Forat Lutfi

Blood (2025) 146 (Supplement 1): 7630.

https://doi.org/10.1182/blood-2025-7630

Published: 2025

Journal Articles

Real-world treatment patterns and survival outcomes in second and third line settings in large B-cell lymphoma (LBCL)

Joseph McGuirk, Miguel-Angel Perales, Mark Fesen, Jeremy Snider, Matt Bye, Anthony Proli, Blythe Adamson, Samuel Hong, Babatunde Adedokun, Hil Hsu

Blood (2025) 146 (Supplement 1): 4503.

https://doi.org/10.1182/blood-2025-4503

Published: 2025

Journal Articles

Impact of pre-transplant anxiety and depression on outcomes of AML patients after allogeneic transplantation

Neda Amirmokhtari, Hannah Katz, Elizabeth Muenks, Jianzheng Wu, Joseph McGuirk, Tara Lin

Blood (2025) 146 (Supplement 1): 2851.

https://doi.org/10.1182/blood-2025-2851

Published: 2025

Journal Articles

Parkinsonism and other non-immune effector cell-associated neurotoxicities related to BCMA-directed chimeric antigen receptor T-cell therapy

Paul Worsley, Jianzheng Wu, Isuru Ratnayake, Dinesh Mudaranthakam, Al-Ola Abdallah, Jeries Kort, Evguenia Bhurtel, Leyla Shune, Joseph McGuirk, Muhammad Nashatizadeh, Nausheen Ahmed, Forat Lutfi

Blood (2025) 146 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2025-2389

Published: 2025

Journal Articles

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Moazzam Shahzad, Muhammad Kashif Amin, Rehan Ishaque, Mahad Zamir, Muhammad Junaid Azhar, Syed Aftab Haider Kamran, Muhammad Abdullah, Roma Bai, Ammara Saleem, Hammad Shafi, Raheel Iftikhar, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7816.

https://doi.org/10.1182/blood-2025-7816

Published: 2025

Journal Articles

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

Zauha fawad Memon, Sibgha Fawad Memon, Rehan Ishaque, Sarmad Masaud, Matia Fawad Memon, Amna Ikram, Shajadi Patan, Furqan Tarique Memon, Muhammad Kashif Amin, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 4619.

https://doi.org/10.1182/blood-2025-4619

Published: 2025

Journal Articles

Temporal trends and demographic patterns in Hodgkin and non-Hodgkin lymphoma mortality among u.s. adults: A CDC wonder study

Zauha fawad Memon, Rehan Ishaque, Sibgha Fawad Memon, Matia Fawad Memon, Muhammad Zain Shaikh, Laksh Kumar Ahuja, Muhammad Qasim Qureshi, Muhammad Kashif Amin, Moazzam Shahzad, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 8039.

https://doi.org/10.1182/blood-2025-8039

Published: 2025

Journal Articles

The role of pentamidine for pneumocystis jirovecii prophylaxis in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

Muhammad Kashif Amin, Nabeeha Noor, Muhammad Talha Maqsood, Saniya Ishtiaq, Sadaf Ilyas, Zeeshan Imtiaz, Syed Aftab Haider Kamran, Hammad Shafi, Abhay Mishra, Maggie Nelson, Joseph McGuirk, Moazzam Shahzad, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7797.

https://doi.org/10.1182/blood-2025-7797

Published: 2025

Journal Articles

Outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis using post-transplant cyclophosphamide-based gvhd prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Aroog Khaliq, Muhammad Kashif Amin, Jordan Leal, Olivia Molander, Philip Lubanski, Maggie Nelson, Abdulraheem Yacoub, Anurag Singh, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 2460.

https://doi.org/10.1182/blood-2025-2460

Published: 2025

Journal Articles

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Moazzam Shahzad, Aqeeb Ur Rehman, Shah Rukh, Muhammad Kashif Amin, Amir Kasaeian, Hammad Shafi, Forat Lutfi, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 7684.

https://doi.org/10.1182/blood-2025-7684

Published: 2025

Journal Articles

Outcomes after bone marrow versus peripheral blood matched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based gvhd prophylaxis

Amna Bint I Munir, Aqeeb Ur Rehman, Moazzam Shahzad, Muhammad Kashif Amin, Anurag Singh, Sunil Abhyankar, Mehdi Hamadani, Joseph McGuirk, Muhammad Umair Mushtaq

Blood (2025) 146 (Supplement 1): 6024.

https://doi.org/10.1182/blood-2025-6024

Published: 2025

Journal Articles

Impact of bridging therapies prior to CAR T cell therapy for large B-cell lymphoma: Real-world analysis from the cell therapy consortium

Alexandra Rojek, Alyssa Gibson, Marina Gomez-Llobell, Miguel-Angel Perales, Joseph McGuirk, Stephen Schuster, David Porter, Jamie Brower, Hanan Alharthy, Sairah Ahmed, Richard Maziarz, Veronika Bachanova, Olalekan Oluwole, Anthony Hunter, Peter Riedell

Blood (2025) 146 (Supplement 1): 2707.

https://doi.org/10.1182/blood-2025-2707

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Tumor-infiltrating lymphocyte therapy in lung cancer: A systematic review

Outcomes after bone marrow versus peripheral blood mismatched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Incidence, patterns, and outcomes of adenovirus infections in patients following allogeneic hematopoietic cell transplantation

Outcomes and associated factors after melphalan 140 mg/m² autologous hematopoietic cell transplantation for multiple myeloma in patients over 70 years of age

Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)

Novel composite end-points toxicity/progression-free survival (tfPFS) and toxicity-free complete remission (tfCR100) after CAR-T cell therapy for diffuse large B cell lymphoma: Cell therapy consortium analysis.

Comparative safety and efficacy of bendamustine versus fludarabine/cyclophosphamide prior to chimeric antigen receptor- T cell therapy: A systematic review and meta-analysis

Impact of early bacteremia on clinical outcomes following allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based gvhd prophylaxis

Absolute lymphocyte count (ALC) at apheresis and infusion as a predictor of safety and efficacy for multiple myeloma and B cell malignancies post CAR-T therapy

Real-world treatment patterns and survival outcomes in second and third line settings in large B-cell lymphoma (LBCL)

Impact of pre-transplant anxiety and depression on outcomes of AML patients after allogeneic transplantation

Parkinsonism and other non-immune effector cell-associated neurotoxicities related to BCMA-directed chimeric antigen receptor T-cell therapy

Outcomes of haploidentical hematopoietic stem cell transplantation in low- and middle-income countries: A systematic review and meta-analysis.

Comparative trends in mortality from acute lymphoblastic and Acute Myeloid Leukemia in the United States: A CDC wonder analysis (1999–2020)

Temporal trends and demographic patterns in Hodgkin and non-Hodgkin lymphoma mortality among u.s. adults: A CDC wonder study

The role of pentamidine for pneumocystis jirovecii prophylaxis in allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis

Outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis using post-transplant cyclophosphamide-based gvhd prophylaxis

Sociodemographic and patient-related determinants of outcomes after unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based GVHD prophylaxis

Outcomes after bone marrow versus peripheral blood matched unrelated donor hematopoietic cell transplantation using posttransplant cyclophosphamide-based gvhd prophylaxis

Impact of bridging therapies prior to CAR T cell therapy for large B-cell lymphoma: Real-world analysis from the cell therapy consortium

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only